|
GPATCH8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74546999999192E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.385000E-04 |
| Normal-vs-Stage2 |
2.435800E-03 |
| Normal-vs-Stage3 |
1.37369999997361E-06 |
| Normal-vs-Stage4 |
3.90500000000404E-05 |
| Stage1-vs-Stage2 |
7.811000E-01 |
| Stage1-vs-Stage3 |
6.600500E-02 |
| Stage1-vs-Stage4 |
1.889770E-01 |
| Stage2-vs-Stage3 |
3.110200E-01 |
| Stage2-vs-Stage4 |
5.095000E-01 |
| Stage3-vs-Stage4 |
7.331800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48669999999285E-05 |
| Normal-vs-AfricanAmerican |
5.748100E-02 |
| Normal-vs-Asian |
1.285590E-02 |
| Caucasian-vs-AfricanAmerican |
3.817800E-01 |
| Caucasian-vs-Asian |
3.259000E-01 |
| AfricanAmerican-vs-Asian |
8.977200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18309999996846E-06 |
| Normal-vs-Female |
9.91500000000478E-05 |
| Male-vs-Female |
1.892390E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.961300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.182160E-04 |
| Normal-vs-Age(61-80Yrs) |
9.3205999995849E-07 |
| Normal-vs-Age(81-100Yrs) |
1.436780E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.112200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.942500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.155160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.498600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.029200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.962800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.100200E-03 |
| Classical-VS-Follicular |
1.476070E-03 |
| Classical-VS-Other |
2.720600E-01 |
| Classical-VS-Normal |
1.344640E-03 |
| Tall-VS-Follicular |
8.067000E-01 |
| Tall-VS-Other |
9.033600E-01 |
| Tall-VS-Normal |
2.41319999999545E-05 |
| Follicular-VS-Other |
9.907400E-01 |
| Follicular-VS-Normal |
2.64969999996811E-06 |
| Other-VS-Normal |
2.587900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.39949999999434E-05 |
| Normal-vs-N1 |
7.241200E-04 |
| N0-vs-N1 |
8.923400E-01 |
|
|
